English
简体中文
Total: £ 56.28
Published Date: 2025-07-10 | Pages: 102 | Tables: 109 | Service & Software
The global market for AI Drug Target Discovery Service was valued at US$ 3394 million in the year 2024 and is projected to reach a revised size of US$ 14186 million by 2031, growing at a CAGR of 23.0% during the forecast period.
AI Drug Target Discovery Service refers to a method that uses artificial intelligence technology to identify, validate and screen potential drug targets. By analyzing and mining massive biomedical data, this method uses machine learning, deep learning and other algorithms to predict and identify disease-related biomolecules, which can be used as targets for drug development, thereby accelerating the process of new drug discovery and research and development.
Market Opportunities and Key Drivers:
The AI Drug Target Discovery Service is experiencing unprecedented growth opportunities, with the core driving forces stemming from the triple resonance of technological innovation, policy support, and market demand. This growth is attributed to the disruptive impact of AI technology on the efficiency of drug development: traditional target discovery takes 5-7 years, while AI algorithms can shorten the cycle to 1-2 years, reducing the research cost by 40%-60%, and increasing the success rate of preclinical target validation from less than 10% to over 25%. At the policy level, China's "14th Five-Year Plan" has designated AI pharmaceuticals as a key development area, and the US FDA has also launched an "AI Priority" fast-track approval channel to accelerate the entry of AI-discovered targets into clinical trials. At the market demand end, the explosive growth in the treatment needs for chronic diseases and rare diseases has become the core driving force - for instance, AI successfully identified PD-L1's drug resistance mechanism-derived targets (such as LAG-3) in tumor target discovery, promoting the iteration of immunotherapy; in the rare disease field, AI analyzed the data from the 10,000 Genomes Project to identify new targets such as SMN2 enhancer for SMA (spinal muscular atrophy), filling the gaps in traditional research. Additionally, the capital enthusiasm continues to rise: in 2024, the global financing in the AI pharmaceutical field exceeded 12 billion US dollars, with target discovery enterprises accounting for 35% (such as Insilico Medicine, Exscientia, etc.), and pharmaceutical giants such as Eli Lilly and Roche have deeply invested in AI target platforms through cooperation or acquisition, further catalyzing industry expansion.
Challenges and Future Directions:
The AI Drug Target Discovery Service still faces multiple challenges in terms of data, technology, and ethics. The primary data bottleneck is the foremost issue: the fragmentation of biomedical data and privacy barriers lead to a lack of high-quality training data, for example, only 15% of protein interaction data related to target association meet the requirements of AI models, and the anonymization of patient genetic data weakens the accuracy of target prediction. The insufficient technical maturity also restricts application: deep learning models have poor explainability in predicting target mechanisms (the "black box problem"), resulting in 30% of AI predicted targets being unable to be verified through wet experiments; at the same time, the shortage of interdisciplinary talents separates algorithm development from biological validation, prolonging the transformation cycle. The regulatory and ethical risks are equally prominent: there are no unified standards for the intellectual property rights of AI-generated targets in various countries (such as whether AI can be listed as an inventor of a patent), and algorithm biases may ignore the characteristics of specific populations (such as the missing rate of genetic variation data for African Americans reaching 40%), exacerbating medical inequality. The future direction will focus on technology integration and ecosystem reconstruction: on the one hand, multimodal AI models (such as AlphaFold 3 combined with structure prediction and molecular dynamics simulation) can improve the accuracy of target screening, while quantum computing will solve the computational bottleneck of protein folding simulation; on the other hand, federated learning technology can integrate cross-border medical data under privacy protection, building a "global brain" for target discovery. At the industry level, the "AI + CRO" model (such as the collaboration between Wuxi Chemtech and Insilico) will promote the large-scale validation of targets, and blockchain technology may establish new standards for target data traceability and intellectual property rights confirmation. Ultimately, AI target discovery will evolve from a tool to a platform ecosystem, achieving a paradigm shift from "single-target breakthrough" to "disease network targeting" through open collaboration.
This report aims to provide a comprehensive presentation of the global market for AI Drug Target Discovery Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Drug Target Discovery Service.
The AI Drug Target Discovery Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Drug Target Discovery Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Drug Target Discovery Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Exscientia
Atomwise
Benevolent AI
Insitro
Xaira Therapeutics
Tempus AI
AbCellera
Recursion
Iktos
Genialis
Anima Biotech
BPGbio
Cradle
Isomorphic Labs
Generate Biomedicines
Latent Labs
Relay Therapeutics
Model Medicines
Nimbus Therapeutics
Schrödinger
XtalPi
Insilico Medicine
Drug Farm
BioMap
Segment by Type
Target Identification Based on Omics Data and Biological Networks
Target Mining Based on Literature and Knowledge Graphs
Target Prediction Based on Structural Bioinformatics
Target Discovery Based on Phenotypic Screening and Virtual Patients
Segment by Application
Pharmaceutical Company
CRO and Universities
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Drug Target Discovery Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Target Discovery Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Target Identification Based on Omics Data and Biological Networks
1.2.3 Target Mining Based on Literature and Knowledge Graphs
1.2.4 Target Prediction Based on Structural Bioinformatics
1.2.5 Target Discovery Based on Phenotypic Screening and Virtual Patients
1.3 Market by Application
1.3.1 Global AI Drug Target Discovery Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 CRO and Universities
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Target Discovery Service Market Perspective (2020-2031)
2.2 Global AI Drug Target Discovery Service Growth Trends by Region
2.2.1 Global AI Drug Target Discovery Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI Drug Target Discovery Service Historic Market Size by Region (2020-2025)
2.2.3 AI Drug Target Discovery Service Forecasted Market Size by Region (2026-2031)
2.3 AI Drug Target Discovery Service Market Dynamics
2.3.1 AI Drug Target Discovery Service Industry Trends
2.3.2 AI Drug Target Discovery Service Market Drivers
2.3.3 AI Drug Target Discovery Service Market Challenges
2.3.4 AI Drug Target Discovery Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Drug Target Discovery Service Players by Revenue
3.1.1 Global Top AI Drug Target Discovery Service Players by Revenue (2020-2025)
3.1.2 Global AI Drug Target Discovery Service Revenue Market Share by Players (2020-2025)
3.2 Global Top AI Drug Target Discovery Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI Drug Target Discovery Service Revenue
3.4 Global AI Drug Target Discovery Service Market Concentration Ratio
3.4.1 Global AI Drug Target Discovery Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Target Discovery Service Revenue in 2024
3.5 Global Key Players of AI Drug Target Discovery Service Head office and Area Served
3.6 Global Key Players of AI Drug Target Discovery Service, Product and Application
3.7 Global Key Players of AI Drug Target Discovery Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Target Discovery Service Breakdown Data by Type
4.1 Global AI Drug Target Discovery Service Historic Market Size by Type (2020-2025)
4.2 Global AI Drug Target Discovery Service Forecasted Market Size by Type (2026-2031)
5 AI Drug Target Discovery Service Breakdown Data by Application
5.1 Global AI Drug Target Discovery Service Historic Market Size by Application (2020-2025)
5.2 Global AI Drug Target Discovery Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI Drug Target Discovery Service Market Size (2020-2031)
6.2 North America AI Drug Target Discovery Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI Drug Target Discovery Service Market Size by Country (2020-2025)
6.4 North America AI Drug Target Discovery Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Drug Target Discovery Service Market Size (2020-2031)
7.2 Europe AI Drug Target Discovery Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI Drug Target Discovery Service Market Size by Country (2020-2025)
7.4 Europe AI Drug Target Discovery Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI Drug Target Discovery Service Market Size (2020-2031)
8.2 Asia-Pacific AI Drug Target Discovery Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI Drug Target Discovery Service Market Size by Region (2020-2025)
8.4 Asia-Pacific AI Drug Target Discovery Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI Drug Target Discovery Service Market Size (2020-2031)
9.2 Latin America AI Drug Target Discovery Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI Drug Target Discovery Service Market Size by Country (2020-2025)
9.4 Latin America AI Drug Target Discovery Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Drug Target Discovery Service Market Size (2020-2031)
10.2 Middle East & Africa AI Drug Target Discovery Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI Drug Target Discovery Service Market Size by Country (2020-2025)
10.4 Middle East & Africa AI Drug Target Discovery Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exscientia
11.1.1 Exscientia Company Details
11.1.2 Exscientia Business Overview
11.1.3 Exscientia AI Drug Target Discovery Service Introduction
11.1.4 Exscientia Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.1.5 Exscientia Recent Development
11.2 Atomwise
11.2.1 Atomwise Company Details
11.2.2 Atomwise Business Overview
11.2.3 Atomwise AI Drug Target Discovery Service Introduction
11.2.4 Atomwise Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.2.5 Atomwise Recent Development
11.3 Benevolent AI
11.3.1 Benevolent AI Company Details
11.3.2 Benevolent AI Business Overview
11.3.3 Benevolent AI AI Drug Target Discovery Service Introduction
11.3.4 Benevolent AI Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.3.5 Benevolent AI Recent Development
11.4 Insitro
11.4.1 Insitro Company Details
11.4.2 Insitro Business Overview
11.4.3 Insitro AI Drug Target Discovery Service Introduction
11.4.4 Insitro Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.4.5 Insitro Recent Development
11.5 Xaira Therapeutics
11.5.1 Xaira Therapeutics Company Details
11.5.2 Xaira Therapeutics Business Overview
11.5.3 Xaira Therapeutics AI Drug Target Discovery Service Introduction
11.5.4 Xaira Therapeutics Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.5.5 Xaira Therapeutics Recent Development
11.6 Tempus AI
11.6.1 Tempus AI Company Details
11.6.2 Tempus AI Business Overview
11.6.3 Tempus AI AI Drug Target Discovery Service Introduction
11.6.4 Tempus AI Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.6.5 Tempus AI Recent Development
11.7 AbCellera
11.7.1 AbCellera Company Details
11.7.2 AbCellera Business Overview
11.7.3 AbCellera AI Drug Target Discovery Service Introduction
11.7.4 AbCellera Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.7.5 AbCellera Recent Development
11.8 Recursion
11.8.1 Recursion Company Details
11.8.2 Recursion Business Overview
11.8.3 Recursion AI Drug Target Discovery Service Introduction
11.8.4 Recursion Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.8.5 Recursion Recent Development
11.9 Iktos
11.9.1 Iktos Company Details
11.9.2 Iktos Business Overview
11.9.3 Iktos AI Drug Target Discovery Service Introduction
11.9.4 Iktos Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.9.5 Iktos Recent Development
11.10 Genialis
11.10.1 Genialis Company Details
11.10.2 Genialis Business Overview
11.10.3 Genialis AI Drug Target Discovery Service Introduction
11.10.4 Genialis Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.10.5 Genialis Recent Development
11.11 Anima Biotech
11.11.1 Anima Biotech Company Details
11.11.2 Anima Biotech Business Overview
11.11.3 Anima Biotech AI Drug Target Discovery Service Introduction
11.11.4 Anima Biotech Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.11.5 Anima Biotech Recent Development
11.12 BPGbio
11.12.1 BPGbio Company Details
11.12.2 BPGbio Business Overview
11.12.3 BPGbio AI Drug Target Discovery Service Introduction
11.12.4 BPGbio Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.12.5 BPGbio Recent Development
11.13 Cradle
11.13.1 Cradle Company Details
11.13.2 Cradle Business Overview
11.13.3 Cradle AI Drug Target Discovery Service Introduction
11.13.4 Cradle Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.13.5 Cradle Recent Development
11.14 Isomorphic Labs
11.14.1 Isomorphic Labs Company Details
11.14.2 Isomorphic Labs Business Overview
11.14.3 Isomorphic Labs AI Drug Target Discovery Service Introduction
11.14.4 Isomorphic Labs Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.14.5 Isomorphic Labs Recent Development
11.15 Generate Biomedicines
11.15.1 Generate Biomedicines Company Details
11.15.2 Generate Biomedicines Business Overview
11.15.3 Generate Biomedicines AI Drug Target Discovery Service Introduction
11.15.4 Generate Biomedicines Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.15.5 Generate Biomedicines Recent Development
11.16 Latent Labs
11.16.1 Latent Labs Company Details
11.16.2 Latent Labs Business Overview
11.16.3 Latent Labs AI Drug Target Discovery Service Introduction
11.16.4 Latent Labs Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.16.5 Latent Labs Recent Development
11.17 Relay Therapeutics
11.17.1 Relay Therapeutics Company Details
11.17.2 Relay Therapeutics Business Overview
11.17.3 Relay Therapeutics AI Drug Target Discovery Service Introduction
11.17.4 Relay Therapeutics Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.17.5 Relay Therapeutics Recent Development
11.18 Model Medicines
11.18.1 Model Medicines Company Details
11.18.2 Model Medicines Business Overview
11.18.3 Model Medicines AI Drug Target Discovery Service Introduction
11.18.4 Model Medicines Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.18.5 Model Medicines Recent Development
11.19 Nimbus Therapeutics
11.19.1 Nimbus Therapeutics Company Details
11.19.2 Nimbus Therapeutics Business Overview
11.19.3 Nimbus Therapeutics AI Drug Target Discovery Service Introduction
11.19.4 Nimbus Therapeutics Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.19.5 Nimbus Therapeutics Recent Development
11.20 Schrödinger
11.20.1 Schrödinger Company Details
11.20.2 Schrödinger Business Overview
11.20.3 Schrödinger AI Drug Target Discovery Service Introduction
11.20.4 Schrödinger Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.20.5 Schrödinger Recent Development
11.21 XtalPi
11.21.1 XtalPi Company Details
11.21.2 XtalPi Business Overview
11.21.3 XtalPi AI Drug Target Discovery Service Introduction
11.21.4 XtalPi Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.21.5 XtalPi Recent Development
11.22 Insilico Medicine
11.22.1 Insilico Medicine Company Details
11.22.2 Insilico Medicine Business Overview
11.22.3 Insilico Medicine AI Drug Target Discovery Service Introduction
11.22.4 Insilico Medicine Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.22.5 Insilico Medicine Recent Development
11.23 Drug Farm
11.23.1 Drug Farm Company Details
11.23.2 Drug Farm Business Overview
11.23.3 Drug Farm AI Drug Target Discovery Service Introduction
11.23.4 Drug Farm Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.23.5 Drug Farm Recent Development
11.24 BioMap
11.24.1 BioMap Company Details
11.24.2 BioMap Business Overview
11.24.3 BioMap AI Drug Target Discovery Service Introduction
11.24.4 BioMap Revenue in AI Drug Target Discovery Service Business (2020-2025)
11.24.5 BioMap Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI Drug Target Discovery Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Target Identification Based on Omics Data and Biological Networks
Table 3. Key Players of Target Mining Based on Literature and Knowledge Graphs
Table 4. Key Players of Target Prediction Based on Structural Bioinformatics
Table 5. Key Players of Target Discovery Based on Phenotypic Screening and Virtual Patients
Table 6. Global AI Drug Target Discovery Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global AI Drug Target Discovery Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global AI Drug Target Discovery Service Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global AI Drug Target Discovery Service Market Share by Region (2020-2025)
Table 10. Global AI Drug Target Discovery Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global AI Drug Target Discovery Service Market Share by Region (2026-2031)
Table 12. AI Drug Target Discovery Service Market Trends
Table 13. AI Drug Target Discovery Service Market Drivers
Table 14. AI Drug Target Discovery Service Market Challenges
Table 15. AI Drug Target Discovery Service Market Restraints
Table 16. Global AI Drug Target Discovery Service Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global AI Drug Target Discovery Service Market Share by Players (2020-2025)
Table 18. Global Top AI Drug Target Discovery Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Target Discovery Service as of 2024)
Table 19. Ranking of Global Top AI Drug Target Discovery Service Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by AI Drug Target Discovery Service Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of AI Drug Target Discovery Service, Headquarters and Area Served
Table 22. Global Key Players of AI Drug Target Discovery Service, Product and Application
Table 23. Global Key Players of AI Drug Target Discovery Service, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global AI Drug Target Discovery Service Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global AI Drug Target Discovery Service Revenue Market Share by Type (2020-2025)
Table 27. Global AI Drug Target Discovery Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global AI Drug Target Discovery Service Revenue Market Share by Type (2026-2031)
Table 29. Global AI Drug Target Discovery Service Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global AI Drug Target Discovery Service Revenue Market Share by Application (2020-2025)
Table 31. Global AI Drug Target Discovery Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global AI Drug Target Discovery Service Revenue Market Share by Application (2026-2031)
Table 33. North America AI Drug Target Discovery Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America AI Drug Target Discovery Service Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America AI Drug Target Discovery Service Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe AI Drug Target Discovery Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe AI Drug Target Discovery Service Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe AI Drug Target Discovery Service Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific AI Drug Target Discovery Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific AI Drug Target Discovery Service Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific AI Drug Target Discovery Service Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America AI Drug Target Discovery Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America AI Drug Target Discovery Service Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America AI Drug Target Discovery Service Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa AI Drug Target Discovery Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa AI Drug Target Discovery Service Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa AI Drug Target Discovery Service Market Size by Country (2026-2031) & (US$ Million)
Table 48. Exscientia Company Details
Table 49. Exscientia Business Overview
Table 50. Exscientia AI Drug Target Discovery Service Product
Table 51. Exscientia Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 52. Exscientia Recent Development
Table 53. Atomwise Company Details
Table 54. Atomwise Business Overview
Table 55. Atomwise AI Drug Target Discovery Service Product
Table 56. Atomwise Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 57. Atomwise Recent Development
Table 58. Benevolent AI Company Details
Table 59. Benevolent AI Business Overview
Table 60. Benevolent AI AI Drug Target Discovery Service Product
Table 61. Benevolent AI Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 62. Benevolent AI Recent Development
Table 63. Insitro Company Details
Table 64. Insitro Business Overview
Table 65. Insitro AI Drug Target Discovery Service Product
Table 66. Insitro Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 67. Insitro Recent Development
Table 68. Xaira Therapeutics Company Details
Table 69. Xaira Therapeutics Business Overview
Table 70. Xaira Therapeutics AI Drug Target Discovery Service Product
Table 71. Xaira Therapeutics Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 72. Xaira Therapeutics Recent Development
Table 73. Tempus AI Company Details
Table 74. Tempus AI Business Overview
Table 75. Tempus AI AI Drug Target Discovery Service Product
Table 76. Tempus AI Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 77. Tempus AI Recent Development
Table 78. AbCellera Company Details
Table 79. AbCellera Business Overview
Table 80. AbCellera AI Drug Target Discovery Service Product
Table 81. AbCellera Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 82. AbCellera Recent Development
Table 83. Recursion Company Details
Table 84. Recursion Business Overview
Table 85. Recursion AI Drug Target Discovery Service Product
Table 86. Recursion Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 87. Recursion Recent Development
Table 88. Iktos Company Details
Table 89. Iktos Business Overview
Table 90. Iktos AI Drug Target Discovery Service Product
Table 91. Iktos Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 92. Iktos Recent Development
Table 93. Genialis Company Details
Table 94. Genialis Business Overview
Table 95. Genialis AI Drug Target Discovery Service Product
Table 96. Genialis Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 97. Genialis Recent Development
Table 98. Anima Biotech Company Details
Table 99. Anima Biotech Business Overview
Table 100. Anima Biotech AI Drug Target Discovery Service Product
Table 101. Anima Biotech Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 102. Anima Biotech Recent Development
Table 103. BPGbio Company Details
Table 104. BPGbio Business Overview
Table 105. BPGbio AI Drug Target Discovery Service Product
Table 106. BPGbio Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 107. BPGbio Recent Development
Table 108. Cradle Company Details
Table 109. Cradle Business Overview
Table 110. Cradle AI Drug Target Discovery Service Product
Table 111. Cradle Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 112. Cradle Recent Development
Table 113. Isomorphic Labs Company Details
Table 114. Isomorphic Labs Business Overview
Table 115. Isomorphic Labs AI Drug Target Discovery Service Product
Table 116. Isomorphic Labs Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 117. Isomorphic Labs Recent Development
Table 118. Generate Biomedicines Company Details
Table 119. Generate Biomedicines Business Overview
Table 120. Generate Biomedicines AI Drug Target Discovery Service Product
Table 121. Generate Biomedicines Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 122. Generate Biomedicines Recent Development
Table 123. Latent Labs Company Details
Table 124. Latent Labs Business Overview
Table 125. Latent Labs AI Drug Target Discovery Service Product
Table 126. Latent Labs Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 127. Latent Labs Recent Development
Table 128. Relay Therapeutics Company Details
Table 129. Relay Therapeutics Business Overview
Table 130. Relay Therapeutics AI Drug Target Discovery Service Product
Table 131. Relay Therapeutics Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 132. Relay Therapeutics Recent Development
Table 133. Model Medicines Company Details
Table 134. Model Medicines Business Overview
Table 135. Model Medicines AI Drug Target Discovery Service Product
Table 136. Model Medicines Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 137. Model Medicines Recent Development
Table 138. Nimbus Therapeutics Company Details
Table 139. Nimbus Therapeutics Business Overview
Table 140. Nimbus Therapeutics AI Drug Target Discovery Service Product
Table 141. Nimbus Therapeutics Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 142. Nimbus Therapeutics Recent Development
Table 143. Schrödinger Company Details
Table 144. Schrödinger Business Overview
Table 145. Schrödinger AI Drug Target Discovery Service Product
Table 146. Schrödinger Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 147. Schrödinger Recent Development
Table 148. XtalPi Company Details
Table 149. XtalPi Business Overview
Table 150. XtalPi AI Drug Target Discovery Service Product
Table 151. XtalPi Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 152. XtalPi Recent Development
Table 153. Insilico Medicine Company Details
Table 154. Insilico Medicine Business Overview
Table 155. Insilico Medicine AI Drug Target Discovery Service Product
Table 156. Insilico Medicine Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 157. Insilico Medicine Recent Development
Table 158. Drug Farm Company Details
Table 159. Drug Farm Business Overview
Table 160. Drug Farm AI Drug Target Discovery Service Product
Table 161. Drug Farm Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 162. Drug Farm Recent Development
Table 163. BioMap Company Details
Table 164. BioMap Business Overview
Table 165. BioMap AI Drug Target Discovery Service Product
Table 166. BioMap Revenue in AI Drug Target Discovery Service Business (2020-2025) & (US$ Million)
Table 167. BioMap Recent Development
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. AI Drug Target Discovery Service Picture
Figure 2. Global AI Drug Target Discovery Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI Drug Target Discovery Service Market Share by Type: 2024 VS 2031
Figure 4. Target Identification Based on Omics Data and Biological Networks Features
Figure 5. Target Mining Based on Literature and Knowledge Graphs Features
Figure 6. Target Prediction Based on Structural Bioinformatics Features
Figure 7. Target Discovery Based on Phenotypic Screening and Virtual Patients Features
Figure 8. Global AI Drug Target Discovery Service Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global AI Drug Target Discovery Service Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Company Case Studies
Figure 11. CRO and Universities Case Studies
Figure 12. Others Case Studies
Figure 13. AI Drug Target Discovery Service Report Years Considered
Figure 14. Global AI Drug Target Discovery Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global AI Drug Target Discovery Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global AI Drug Target Discovery Service Market Share by Region: 2024 VS 2031
Figure 17. Global AI Drug Target Discovery Service Market Share by Players in 2024
Figure 18. Global AI Drug Target Discovery Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by AI Drug Target Discovery Service Revenue in 2024
Figure 20. North America AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America AI Drug Target Discovery Service Market Share by Country (2020-2031)
Figure 22. United States AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe AI Drug Target Discovery Service Market Share by Country (2020-2031)
Figure 26. Germany AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific AI Drug Target Discovery Service Market Share by Region (2020-2031)
Figure 34. China AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America AI Drug Target Discovery Service Market Share by Country (2020-2031)
Figure 42. Mexico AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa AI Drug Target Discovery Service Market Share by Country (2020-2031)
Figure 46. Israel AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE AI Drug Target Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Exscientia Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 50. Atomwise Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 51. Benevolent AI Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 52. Insitro Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 53. Xaira Therapeutics Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 54. Tempus AI Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 55. AbCellera Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 56. Recursion Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 57. Iktos Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 58. Genialis Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 59. Anima Biotech Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 60. BPGbio Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 61. Cradle Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 62. Isomorphic Labs Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 63. Generate Biomedicines Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 64. Latent Labs Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 65. Relay Therapeutics Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 66. Model Medicines Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 67. Nimbus Therapeutics Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 68. Schrödinger Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 69. XtalPi Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 70. Insilico Medicine Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 71. Drug Farm Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 72. BioMap Revenue Growth Rate in AI Drug Target Discovery Service Business (2020-2025)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
